Browse studies

Find your next paid study

1 recruiting study matching your filters

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

This research is being done to test a new drug called PEEL-224 in combination with two commercially available drugs, Vincristine and Temozolomide, and to deter…

SarcomaSarcoma, EwingDesmoplastic Small Round Cell Tumor+3 more

David S Shulman, MDNCT06709495